NuuVim review
NuuVim is a Texas-based DTC telehealth program offering compounded semaglutide and tirzepatide in both injectable and oral forms — oral access is uncommon here — plus limited brand-name Ozempic and Zepbound.
- Semaglutide
- From $79/mo (all doses, 3-month plan, new patients only, compounded)
- Tirzepatide
- From $133/mo (all doses, 3-month plan, new patients only, compounded)
- Coverage
- Coverage not published
- Brand-name
- Yes
Prices read from NuuVim's own site on . Providers change pricing without notice — check the current figure before you buy.
The scorecard
NuuVim scored on our six Brief Score factors. See the methodology.
What we like
- Low compounded entry pricing — semaglutide from $79/mo, tirzepatide from $133/mo, flat all-dose pricing
- Both injectable and oral compounded options for semaglutide and tirzepatide (oral access is uncommon)
- LegitScript Certified and HIPAA-compliant
- Two named compounding pharmacy partners (Hallandale Pharmacy and Pharmacy Hub), both vetted in our directory
- Operating legal entity disclosed: NuuVim LLC, Texas governing law
The caveats
- There is no month-to-month plan: every rate is billed as one three-month payment
- The advertised $79 and $133 are introductory rates for customers new to GLP-1s; on renewal they become $133 and $199.67
- The site's own llms.txt advertises pricing, FAQ and terms files that all 404
- No state count is published
The brief
Best for: Readers who want low-cost compounded GLP-1s (injection or oral), flat all-dose pricing. NuuVim is a Texas-based DTC telehealth program offering compounded semaglutide and tirzepatide in both injectable and oral forms — oral access is uncommon here — plus limited brand-name Ozempic and Zepbound.
Ranked #330 of 546 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.
Before you decide
The questions readers ask next after reading about NuuVim.
Closest here
The providers scoring nearest NuuVim — the realistic shortlist if you're weighing it.
Weighing NuuVim against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs NuuVim, and every provider that outranks it is listed on the NuuVim alternatives ranking.
- #327Gaya Wellness— Gaya Wellness is a virtual, OB/GYN-led telehealth practice focused on women 40+ for menopause, hormone replacement, and weight loss.62/100
- #328Magnolia Regenerative Medicine— Magnolia Regenerative Medicine charges $119 a month for compounded semaglutide and $199 for tirzepatide; the $99 and $179 it advertises are not available to a new patient.62/100
- #329NativeMed— NativeMed, LLC (nativemed.net) is a Miami, FL-based cash-pay telehealth provider offering compounded semaglutide at promotional $149/mo (regular $299).62/100
- #331OnlyRx— OnlyRx is a cash-pay GLP-1 telehealth platform offering compounded semaglutide and tirzepatide in both injection and oral disintegrating tablet (ODT) forms — an uncommon needle-free option.62/100
- #332Primary Clinic (Direct GLP)— Primary Clinic (Direct GLP) is a Direct Primary Care membership rather than the usual direct-to-consumer GLP-1 marketplace.62/100
- #333Sumbare Wellness— Langhorne, Pennsylvania telehealth platform selling compounded semaglutide, tirzepatide and a low-dose GLP-1 protocol on one flat $199/month plan, with the price confirmed only after a provider reviews you.62/100
More providers we track (24)
- #1 CoreAge Rx94
- #2 Eden91
- #3 Trimi89
- #4 Sesame Care87
- #5 ShedRx87
- #6 Sprout Health86
- #7 HealthRX86
- #8 MadeMed86
- #9 Invigor Medical88
- #10 Telos Rx85
- #11 Enhance MD85
- #12 REMEVi87
- #13 Ro87
- #14 Ondra Health87
- #15 Vaylen87
- #16 Vytora Health87
- #17 No BS RX87
- #18 yourEra84
- #19 Strut Health84
- #20 Effecty86
- #21 NiceRx86
- #22 Curex86
- #23 Amazon One Medical86
- #24 AgelessRx85
515 more are filed too — see every provider we track, ranked.
Pricing, states and verification reflect NuuVim's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on NuuVim's site. Not medical advice; see our disclosure.